Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/631
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPutri, Tiffanny Adora-
dc.date.accessioned2023-03-07T04:07:50Z-
dc.date.available2023-03-07T04:07:50Z-
dc.date.issued2022-06-06-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/631-
dc.description.abstractThe Covid-19 global pandemic caused by SARS-COV-2 has been going on for almost two years and has negatively impacted the global population. The same as other viruses, SARS-COV-2 is continuously Mutating to adapt to the environment, and this may result in negative impacts, such as an increase in virus transmission, virulence, and even resistance to vaccines. Hence, questions regarding whether the currently available vaccines are still effective against the currently circulating SARS-COV-2 Variants have risen and are widely discussed.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesBM 22-048;T202207109-
dc.subjectNext Generation-sequencingen_US
dc.subjectT-cell epitopesen_US
dc.subjectSARS-CoV-2en_US
dc.subjectStructural Proteinsen_US
dc.subjectVaccineen_US
dc.subjectIndonesiaen_US
dc.titleNext-Generaon Sequencing and Predicon of T-cell Epitopes from Structural Proteins of Circulang SARS-CoV-2 Strains in Indonesiaen_US
dc.typeWorking Paperen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
BM 22-048 Tiffanny Adora Putri.pdf
  Restricted Access
Full text3.51 MBAdobe PDFView/Open Request a copy
Cover.pdfCover225.97 kBAdobe PDFView/Open
Abstract.pdfAbstract40.68 kBAdobe PDFView/Open
Chapter 1.pdfChapter 1123.34 kBAdobe PDFView/Open
References.pdfReferences374.26 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.